May 1, 2018 07:00 AM EDT
Pharma

Sanofi/Re­gen­eron’s one-two punch on PC­SK9 price and health da­ta wins a key con­vert as Ex­press Scripts cre­ates ex­clu­sive for­mu­la­ry deal

John Carroll

Editor & Founder

Just 7 weeks af­ter Sanofi $SNY and Re­gen­eron $REGN flagged piv­otal da­ta on a clear mor­tal­i­ty ben­e­fit to be had from its PC­SK9 car­dio drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times